DEA Packaging Therapy Treatment 
The Cannigma
MAY 15, 2023
While costs to access ketamine therapy can be high in some locations, and like any drug ketamine is not a cure-all, some patients and their doctors have been reporting life-changing results when no other treatment provided relief. Patients may want to seek assistance from a certified professional prior to embarking on treatment.
Cannabis Law Report
JULY 1, 2021
In 2017, the FDA designated MDMA a breakthrough therapy for post-traumatic stress disorder, and in 2018 the agency recognized psilocybin as a breakthrough therapy for treatment-resistant depression. In contrast, it is unclear to what extent people most in need of psychedelic therapies will benefit.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JUNE 27, 2022
So this is going to be more of an issue for y’all who specialize in packaging premium bud for smoking. The Drug Enforcement Administration (DEA) said in a letter that marijuana seed that has a delta-9-THC concentration of not more than 0.3% million grant to fund research into the addiction-treatment properties of psychedelics: [link].
Cannabis Law Report
JULY 12, 2019
Ultimately, the cannabinoid system works by way of multiple molecules affecting multiple receptors at once – the entourage effect, and thus such singular approaches to treatment by way of the cannabinoid system are not effective. Another example of cannabinoid mono therapy is the THC pharmaceutical Marinol. References. 1Alexandra L.
The Cannigma
FEBRUARY 16, 2022
I was like, it’d be cool, if whatever rush you get, that runner’s high, that endorphin, I said, if you could get that and package it, and you could just take that on a regular basis as an athlete, wouldn’t that be amazing? And proficiency testing right now, because of the DEA is very limited in what can get sent out.
Expert insights. Personalized for you.
78 
Let's personalize your content